Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Apx001
2. 2091769-17-2
3. Fosmanogepix [inn]
4. Fosmanogepix [usan]
5. Apx-001
6. 1xq871489p
7. E1211
8. (2-amino-3-(3-(4-((pyridin-2-yloxy)methyl)benzyl)isoxazol-5-yl)pyridin-1-ium-1-yl)methyl Hydrogen Phosphate
9. Pyridinium, 2-amino-1-((phosphonooxy)methyl)-3-(3-((4-((2-pyridinyloxy)methyl)phenyl)methyl)-5-isoxazolyl)-, Inner Salt
10. Fosmanogepix (usan/inn)
11. Chembl4297591
12. Schembl22749842
13. Unii-1xq871489p
14. Ex-a5184
15. Who 10818
16. Db15183
17. 1169701-00-1
18. D11694
19. (12-amino-6-oxa-1(3),7(2)-dipyridina-2(5,3)-(1,2)oxazola- 4(1,4)-benzenaheptaphan-11-ium-11-yl)methyl Hydrogen Phosphate
20. (12-amino-6-oxa-1(3),7(2)-dipyridina-2(5,3)-(1,2)oxazola-4(1,4)-benzenaheptaphan-11-ium-11-yl)methyl Hydrogen Phosphate
21. (2-amino-3-(3-((4-(2-pyridyloxymethyl)phenyl)methyl)isoxazol-5-yl)pyridin-1-ium-1-yl)methyl Hydrogen Phosphate
22. [2-amino-3-[3-[[4-(pyridin-2-yloxymethyl)phenyl]methyl]-1,2-oxazol-5-yl]pyridin-1-ium-1-yl]methyl Hydrogen Phosphate
| Molecular Weight | 468.4 g/mol |
|---|---|
| Molecular Formula | C22H21N4O6P |
| XLogP3 | 1.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 9 |
| Exact Mass | 468.11987140 g/mol |
| Monoisotopic Mass | 468.11987140 g/mol |
| Topological Polar Surface Area | 148 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 644 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Fosmanogepix manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fosmanogepix, including repackagers and relabelers. The FDA regulates Fosmanogepix manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fosmanogepix API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fosmanogepix supplier is an individual or a company that provides Fosmanogepix active pharmaceutical ingredient (API) or Fosmanogepix finished formulations upon request. The Fosmanogepix suppliers may include Fosmanogepix API manufacturers, exporters, distributors and traders.
Fosmanogepix Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fosmanogepix GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fosmanogepix GMP manufacturer or Fosmanogepix GMP API supplier for your needs.
A Fosmanogepix CoA (Certificate of Analysis) is a formal document that attests to Fosmanogepix's compliance with Fosmanogepix specifications and serves as a tool for batch-level quality control.
Fosmanogepix CoA mostly includes findings from lab analyses of a specific batch. For each Fosmanogepix CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fosmanogepix may be tested according to a variety of international standards, such as European Pharmacopoeia (Fosmanogepix EP), Fosmanogepix JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fosmanogepix USP).
LOOKING FOR A SUPPLIER?
